Last edition
News about "Fabry disease "
GC Biopharma, Hanmi Pharma Secure IND Clearance for Phase 1/2 Clinical Trial
LA-GLA is an innovative new drug for the treatment of Fabry disease as the world's first once-monthly subcutaneous treatment, which is being co-developed by GC Biopharma and Hanmi Pharmaceutical.
Fabry Disease | 03/09/2024 | By Aishwarya | 282
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members